Rajnish Wellness Share Price Today | Stock Price & Rajnish Wellness Share Screener
As of October 5, 2026, the live Rajnish Wellness share price (BSE: RAJNISH) is ₹0.36, unchanged from the previous close, with shares trading between ₹0.35 and ₹0.37 in today's trading session, and a 52-week range of ₹0.36–₹0.86. Check RAJNISH 52-week high low for the annual price range and momentum. Use the Rajnish Wellness stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Rajnish Wellness opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹169 and net income of ₹-5, with EBITDA of ₹-8, an operating margin of -4.0% and a profit margin of -3.0%.
Rajnish Wellness Share Price Chart
Track the current stock price of Rajnish Wellness with an interactive chart. Analyse RAJNISH share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Rajnish Wellness stock quote in one place.
The quote of ₹0.36 sits between the 52-week low of ₹0.36 and the 52-week high of ₹0.86.
Rajnish Wellness Company Profile - Fundamental Screener
Screen Rajnish Wellness company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for RAJNISH shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE685Z01033.
Company Details
Classification
Identifiers and Leadership
Rajnish Wellness Balance Sheet Screener
Screen RAJNISH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹109, up from ₹91 in 2025.
Latest statistics put total assets at ₹109 and shareholder funds at ₹103.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 109 | 91 | 106 | 99 | 35 | 35 | 33 | 32 | 18 | 8 |
| Current Assets | 84 | 75 | 81 | 38 | 34 | 33 | 33 | 31 | 17 | 8 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 3 | 3 | 6 | 10 | 9 | 9 | 6 | 1 | 2 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 103 | 84 | 84 | 83 | 22 | 22 | 22 | 22 | 6 | 1 |
| Share Capital | 102 | 77 | 77 | 77 | 11 | 5 | 5 | 5 | 3 | 0 |
| Reserves & Surplus | 1 | 7 | 7 | 6 | 12 | 17 | 17 | 18 | 3 | 1 |
Rajnish Wellness Income Statement Screener - Profit & Revenue Analysis
Screen Rajnish Wellness income statement and profit fundamentals. Analyze RAJNISH quarterly results. Rajnish Wellness reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹169 and net profit was ₹-5, equal to earnings per unit of ₹-0.10, at an operating margin of -4%.
In that period expenses were ₹177, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹143 and net profit of ₹-6.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | ||||||||||||
| Revenue | 169 | 143 | 49 | 77 | 28 | 27 | 17 | 14 | 42 | 29 | 25 | 13 |
| Expenses | 177 | 151 | 49 | 75 | 27 | 27 | 17 | 14 | 35 | 24 | 24 | 13 |
Operating Costs and Margins | ||||||||||||
| EBITDA | -8 | -8 | 1 | 2 | 1 | 1 | 1 | 0 | 7 | 5 | 1 | 1 |
| Operating Profit % | -4.00% | -7.00% | 0.00% | 3.00% | -4.00% | -1.00% | -24.00% | 1.00% | 16.00% | 12.00% | 5.00% | 4.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 |
Profit and Earnings | ||||||||||||
| Profit Before Tax | -8 | -8 | 0 | 1 | 1 | 1 | 0 | -1 | 6 | 4 | 1 | 1 |
| Tax | 0 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 |
| Net Profit | -5 | -6 | 0 | 1 | 1 | 0 | 0 | -1 | 4 | 2 | 1 | 0 |
| EPS | -0.10 | -0.62 | 0.00 | 0.01 | 0.01 | 0.37 | 0.21 | -1.30 | 9.75 | 55.71 | 127.74 | 64.69 |
Rajnish Wellness Cash Flow Screener - Liquidity Fundamentals
Screen RAJNISH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹9, and net cash flow was an inflow of ₹9.
Over the same period, investing activities used ₹7 and financing activities provided ₹25.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | -9 | -4 | 2 | -62 | 0 | 0 | -7 | -9 | -3 | -2 |
| Investing Activities | -7 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financing and Net Cash | ||||||||||
| Financing Activities | 25 | -5 | -2 | 62 | 1 | 0 | 5 | 11 | 3 | 1 |
| Net Cash Flow | 9 | 0 | 0 | -1 | 1 | 0 | -2 | 1 | 0 | 0 |
Rajnish Wellness Shareholding Pattern Screener
See Rajnish Wellness shareholding pattern with promoter, FII, and DII holdings. Check Rajnish Wellness promoter holding and ownership changes for RAJNISH on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Jun, promoters held 9.16%, foreign institutions 0.43%, domestic institutions 0.00% and the public 85.19%, spread across 158,442 shareholders.
The shareholder count was 158,442 in 2026-Jun, compared with 160,259 in 2026-Mar.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 9.16% | 9.16% | 9.16% | 9.16% | 7.41% | 7.41% | 7.41% | 16.24% |
Institutional Investors | ||||||||
| FII Holding | 0.43% | 0.43% | 0.43% | 0.43% | 0.57% | 0.57% | 0.00% | 0.20% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 85.19% | 86.00% | 85.39% | 79.89% | 82.53% | 77.12% | 77.34% | 51.27% |
| Other Holding | 5.22% | 4.41% | 5.02% | 10.52% | 9.50% | 14.90% | 15.25% | 32.30% |
| Shareholder Count | 158,442 | 160,259 | 162,955 | 165,636 | 165,797 | 166,517 | 160,311 | 97,370 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Rajnish Wellness. Rajnish Wellness dividend yield can be compared with peers and other stocks in the market.
Rajnish Wellness Stock Index Membership - Nifty & Sensex
See which indices include Rajnish Wellness stock. Check RAJNISH index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Rajnish Wellness Market Events Screener - Corporate Actions
Get Rajnish Wellness corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Rajnish Wellness stock events that may affect RAJNISH share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 26, 2026, with a record date of September 26, 2026.
It is followed by Quarterly Result Announcement dated August 13, 2026 and Quarterly Result Announcement dated May 30, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-26 | 2026-09-26 | Annual General Meeting | NA | -2.50% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | 0.00% |
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | -2.22% |
| 2026-02-07 | 2026-02-07 | Quarterly Result Announcement | NA | -2.00% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 8.22% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | -15.45% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -2.04% |
| 2025-06-03 | 2025-06-03 | Rights | 19:30 | 3.19% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -2.11% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -1.75% |
| 2024-10-16 | 2024-10-16 | Quarterly Result Announcement | NA | -12.78% |
| 2024-09-24 | 2024-09-24 | Annual General Meeting | NA | -15.63% |
| 2022-07-22 | 2022-07-22 | Split | 2:10 | 45.42% |
| 2022-07-21 | 2022-07-22 | Bonus | 2:1 | 14.54% |
| 2021-12-23 | Bonus | 5:4 | - |
Rajnish Wellness Competitors Screener - Peer Stocks Comparison
Screen RAJNISH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 447,476 | 36.44 | 61,674 | 12.69% | 11,565 | 47.42 |
| Divis Laboratories | 250,363 | 86.51 | 11,067 | 13.95% | 2,568 | 58.71 |
| Torrent Pharmaceuticals | 186,152 | 85.91 | 13,886 | 20.34% | 2,138 | 48.14 |
| Zydus Life Science | 120,798 | 26.32 | 27,658 | 17.64% | 5,026 | 61.81 |
| Cipla | 111,426 | 33.44 | 29,045 | 2.24% | 3,870 | 44.03 |
| Laurus Labs | 106,838 | 99.70 | 6,868 | 22.01% | 890 | 58.00 |
| Mankind Pharma | 105,107 | 48.73 | 14,636 | 14.85% | 1,938 | 64.24 |
| Dr Reddys Laboratories | 104,492 | 32.05 | 35,059 | 3.90% | 4,158 | 69.59 |
| Aurobindo Pharma | 97,682 | 26.36 | 34,145 | 5.56% | 3,503 | 54.69 |
| Lupin | 93,829 | 16.99 | 29,039 | 26.75% | 5,356 | 34.02 |
Rajnish Wellness Company Announcements - News & Reports Screener
Screen RAJNISH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated .
The next most recent announcements are dated October 5, 2026 and October 3, 2026.
| Date | Update | Actions |
|---|---|---|
| Shareholder Meeting / Postal Ballot-Scrutinizers Report | - | |
| 2026-10-05 | Closure of Trading Window | - |
| 2026-10-03 | Proceedings Of The 11Th Annual General Meeting Of Rajnish Wellness Limited Held For The Financial Year 2025-2026 On 26Th September 2026. | - |
| 2026-10-03 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-05 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-09-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-04 | Intimation Related To Shareholders Whose Email Is Not Registered With RTA | - |
| 2026-09-04 | Intimation Related To Book Closure For The Purpose Of AGM | - |
| 2026-09-04 | Notice Of The 11Th Annual General Meeting Of The Company Scheduled To Be Held Through VC/OAVM On Saturday The 26Th September 2026 | - |
| 2026-09-04 | Reg. 34 (1) Annual Report. | - |
| 2026-08-31 | Board Meeting Outcome for Outcome Of Board Meeting Held On Monday The 31St Of August 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | - |
| 2026-08-14 | Submission Of Newspaper Clippings Of Un-Audited Financial Results For Quarter Ended 30Th June 2026 | - |
| 2026-08-13 | Un-Audited Standalone Financial Results For The Quarter Ended 30Th June 2026 | - |
| 2026-08-13 | Board Meeting Outcome for Outcome Of Board Meeting Held Today On Thursday The 13Th August 2026 | - |
| 2026-08-10 | Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI Listing Obligation And Disclosure Requirements 2015 For Holding Board Meeting For Approval Of Un-Audited Financial Results For The Quarter And Year Ended 30Th June 2026 And Other Matters | - |
| 2026-07-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-25 | Closure of Trading Window | - |
| 2026-06-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-30 | Declaration Of Results For The Quarter And Year Ended 31St March 2026. | - |
| 2026-05-30 | Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Saturday 30Th May 2026 | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹0.36, within a 52-week range of ₹0.36 to ₹0.86. The P/E ratio is -7.60 and the P/B ratio is 0.38, with earnings per unit of ₹-0.62. Market capitalisation stands at ₹39.62 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 12 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.